Step Stone Group LP Entrada Therapeutics, Inc. Transaction History
Step Stone Group LP
- $245 Million
- Q3 2024
A detailed history of Step Stone Group LP transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Step Stone Group LP holds 761,277 shares of TRDA stock, worth $13.4 Million. This represents 4.98% of its overall portfolio holdings.
Number of Shares
761,277
Previous 761,277
-0.0%
Holding current value
$13.4 Million
Previous $10.8 Million
12.21%
% of portfolio
4.98%
Previous 2.47%
Shares
3 transactions
Others Institutions Holding TRDA
# of Institutions
101Shares Held
28.1MCall Options Held
34.5KPut Options Held
16.4K-
Baker Bros. Advisors LP New York, NY4.87MShares$85.4 Million0.83% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$77.7 Million48.7% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$77.4 Million28.09% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.05MShares$53.6 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.71MShares$30.1 Million0.01% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $551M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...